Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

160.17
+0.53000.33%
Pre-market: 161.261.09+0.68%05:25 EDT
Volume:2.23M
Turnover:356.02M
Market Cap:248.42B
PE:23.98
High:161.51
Open:161.43
Low:158.13
Close:159.64
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.64
T/O Rate:0.15%
Dividend:3.17
Dividend Rate:1.98%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.94
PE(LYR):24.49

Loading ...

Dizhe Pharma Surpasses 500 Million Yuan in First-Half Revenue, Seals Global Exclusive Licensing Pact with AstraZeneca for Sunvozertinib

Deep News
·
Aug 20

Third Indication Approved in China for AstraZeneca's Ultomiris

Stock News
·
Aug 20

Goldman Sachs Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Aug 20

AstraZeneca PLC Stock (AZN) Moved Up by 3.40% on Aug 19: What Signal Does It Send?

TradingKey
·
Aug 20

Movement Alert|AstraZeneca PLC Rises 3.1% in Regular Trading, Multiple Positive Phase III Lung Cancer Results Coupled with Pharma Sector Strength

Market Focus
·
Aug 19

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19

UBS Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Aug 19

AstraZeneca Rises Tuesday, Outperforms Market

Dow Jones
·
Aug 19

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Citi Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Aug 18

AstraZeneca's Biologic Therapy Receives Dual Indication Approval for Launch in China

Stock News
·
Aug 18

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 18

AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial

TIPRANKS
·
Aug 17

Breakthrough: AstraZeneca and Daiichi Sankyo's ADC Shows Strong Efficacy in First-Line Lung Cancer Therapy

Stock News
·
Aug 17

AstraZeneca (AZN) Gets a Buy from J.P. Morgan

TIPRANKS
·
Aug 17

AstraZeneca Discontinues Phase 3 Lung Cancer Trial for Volrustomig Combination

MT Newswires Live
·
Aug 17

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 15

AstraZeneca’s STEP Asthma Trial Completion: What It Could Mean for AZN Investors

TIPRANKS
·
Aug 14

New Approval in China for Enhertu, a Key Antibody-Drug Conjugate from Daiichi Sankyo and AstraZeneca

Stock News
·
Aug 13

AstraZeneca PLC Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 13